Analysis: Launch prices for brand name, generic drugs have skyrocketed

The average launch prices for new brand-name drugs and new generic drugs have skyrocketed since 2006, according to an analysis from 46brooklyn, a drug research firm. Using data from Elsevier's Gold Standard Drug Database and the federal government, the analysis found that the median monthly price of a new brand-name drug increased 381% (from $150 to $722) from 2006-2019 while the median monthly price of a new generic drug increased 712% (from about $100 to almost $800) during that period. The report also found that nearly 80% of all generic drugs studied had no decrease in their average wholesale price in the past five years.